miR-214-3p Targets β-Catenin to Regulate Depressive-like Behaviors Induced by Chronic Social Defeat Stress in Mice

• Published in: Cerebral cortex (New York, N.Y. 1991) N.Y. 1991), 2019-04, Vol.29 (4), p.1509-1519
• Main Authors: Deng, Zhi-Fang, Zheng, Hui-Ling, Chen, Jian-Guo, Luo, Yi, Xu, Jun-Feng, Zhao, Gang, Lu, Jia-Jing, Li, Hou-Hong, Gao, Shuang-Qi, Zhang, Deng-Zheng, Zhu, Ling-Qiang, Zhang, Yong-Hui, Wang, Fang
• Format: Article
• Language: English
• Subjects: Administration, Intranasal; Animals; Antagomirs - administration & dosage; beta Catenin - genetics; beta Catenin - physiology; Claudin-1 - genetics; Dendritic Spines - drug effects; Dendritic Spines - physiology; Depression - etiology; Depression - genetics; Depression - physiopathology; Excitatory Postsynaptic Potentials - drug effects; Gene Expression Regulation; Hippocampus - drug effects; Hippocampus - physiopathology; Male; Mice, Inbred C57BL; MicroRNAs - antagonists & inhibitors; MicroRNAs - genetics; MicroRNAs - physiology; Prefrontal Cortex - drug effects; Prefrontal Cortex - physiopathology; Stress, Psychological - genetics; Stress, Psychological - physiopathology
• ISSN: 1047-3211; 1460-2199
• DOI: 10.1093/cercor/bhy047

Abstract β-Catenin has been implicated in major depressive disorder (MDD), which is associated with synaptic plasticity and dendritic arborization. MicroRNAs (miRNA) are small noncoding RNAs containing about 22 nucleotides and involved in a variety of physiological and pathophysiological process, but their roles in MDD remain largely unknown. Here, we investigated the expression and function of miRNAs in the mouse model of chronic social defeat stress (CSDS). The regulation of β-catenin by selected miRNA was validated by silico prediction, target gene luciferase reporter assay, and transfection experiment in neurons. We demonstrated that the levels of miR-214-3p, which targets β-catenin transcripts were significantly increased in the medial prefrontal cortex (mPFC) of CSDS mice. Antagomir-214-3p, a neutralizing inhibitor of miR-214-3p, increased the levels of β-catenin and reversed the depressive-like behavior in CSDS mice. Meanwhile, antagomir-214-3p increased the amplitude of miniature excitatory postsynaptic current (mEPSC) and the number of dendritic spines in mPFC of CSDS mice, which may be related to the elevated expression of cldn1. Furthermore, intranasal administered antagomir-214-3p also significantly increased the level of β-catenin and reversed the depressive-like behaviors in CSDS mice. These results may represent a new therapeutic target for MDD.